Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even ...
Tag: Eli Lilly and Co
Here are 3 forces that drove a whirlwind week for the stock market
An avalanche of selling on Friday crushed the stock market, a dramatic reversal from record highs earlier in the week. ...
Here’s our monthly update on all 33 portfolio stocks, including 4 to buy right now
The CNBC Investing Club on Wednesday held its May Monthly Meeting, featuring Jim Cramer and Jeff Marks, director of portfolio analysis, covering ...
Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary ...
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't ...
Trump administration sets up to 100% tariffs on some imported drugs, with many companies exempt
The Trump administration on Thursday imposed new tariffs on branded drugs from pharmaceutical companies that have not struck deals with ...
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake ...
U.S. executives, from Apple to Eli Lilly, revamp their push into the world’s second-largest economy at the China Development Forum
Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the China Development ...
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
A mini burger, mini fries and mini beer, Clinton Hall's "Teeny Weeny Mini Meal", is pictured next to a regular-sized ...
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients, ...
